Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Artrya Limited ( (AU:AYA) ) has shared an announcement.
Artrya Limited has announced the quotation of 12,500 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code AYA, effective from October 23, 2025. This move is part of the company’s strategy to expand its capital base, potentially enhancing its market presence and operational capabilities in the healthcare technology sector.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare technology industry, focusing on developing innovative solutions for the diagnosis and management of coronary artery disease. The company leverages advanced AI and machine learning technologies to enhance cardiovascular health outcomes.
Average Trading Volume: 770,831
Technical Sentiment Signal: Buy
Current Market Cap: A$512.7M
For a thorough assessment of AYA stock, go to TipRanks’ Stock Analysis page.